IL130291A0 - Compositions and methods for administering pneumococcal DNA - Google Patents

Compositions and methods for administering pneumococcal DNA

Info

Publication number
IL130291A0
IL130291A0 IL13029197A IL13029197A IL130291A0 IL 130291 A0 IL130291 A0 IL 130291A0 IL 13029197 A IL13029197 A IL 13029197A IL 13029197 A IL13029197 A IL 13029197A IL 130291 A0 IL130291 A0 IL 130291A0
Authority
IL
Israel
Prior art keywords
administering
compositions
methods
pneumococcal dna
pneumococcal
Prior art date
Application number
IL13029197A
Other languages
English (en)
Original Assignee
Univ Alabama
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Alabama filed Critical Univ Alabama
Publication of IL130291A0 publication Critical patent/IL130291A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C07K14/3156—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci from Streptococcus pneumoniae (Pneumococcus)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
IL13029197A 1996-12-04 1997-12-04 Compositions and methods for administering pneumococcal DNA IL130291A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US75950596A 1996-12-04 1996-12-04
PCT/US1997/022847 WO1998024927A1 (en) 1996-12-04 1997-12-04 Compositions and methods for administering pneumococcal dna

Publications (1)

Publication Number Publication Date
IL130291A0 true IL130291A0 (en) 2000-06-01

Family

ID=25055905

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13029197A IL130291A0 (en) 1996-12-04 1997-12-04 Compositions and methods for administering pneumococcal DNA

Country Status (9)

Country Link
US (1) US20020102242A1 (de)
EP (1) EP1019522A4 (de)
JP (1) JP2002514061A (de)
AU (1) AU5523798A (de)
CA (1) CA2274095A1 (de)
IL (1) IL130291A0 (de)
NO (1) NO992665L (de)
WO (1) WO1998024927A1 (de)
ZA (1) ZA9710934B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002362447A1 (en) * 2001-10-03 2003-04-14 University Of Rochester Human glandular kallikrein (hk2)-specific monoclonal antibodies that enhance or inhibit the enzymatic activity of hk2
US20120135037A1 (en) 2009-06-01 2012-05-31 Mizel Steven B Flagellin fusion proteins and conjugates comprising pneumococcus antigens and methods of using the same
IN2014CN04332A (de) 2011-12-14 2015-09-04 Ineos Europe Ag
US9616114B1 (en) 2014-09-18 2017-04-11 David Gordon Bermudes Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity
US11129906B1 (en) 2016-12-07 2021-09-28 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
US11180535B1 (en) 2016-12-07 2021-11-23 David Gordon Bermudes Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria
US11471497B1 (en) 2019-03-13 2022-10-18 David Gordon Bermudes Copper chelation therapeutics
US10973908B1 (en) 2020-05-14 2021-04-13 David Gordon Bermudes Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated salmonella as a vaccine

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5476929A (en) * 1991-02-15 1995-12-19 Uab Research Foundation Structural gene of pneumococcal protein
DK0571538T5 (da) * 1991-02-15 2002-03-04 Uab Research Foundation Strukturgen for pneumokokprotein

Also Published As

Publication number Publication date
NO992665L (no) 1999-08-04
US20020102242A1 (en) 2002-08-01
AU5523798A (en) 1998-06-29
EP1019522A4 (de) 2002-06-19
NO992665D0 (no) 1999-06-02
WO1998024927A1 (en) 1998-06-11
ZA9710934B (en) 1998-09-10
CA2274095A1 (en) 1998-06-11
EP1019522A1 (de) 2000-07-19
JP2002514061A (ja) 2002-05-14

Similar Documents

Publication Publication Date Title
IL127545A0 (en) Compositions and methods for administering borrelia DNA
GB2331015B (en) Therapeutic methods and compositions involving isoflavones
ZA978868B (en) Vaccine composition
GB9616411D0 (en) Shampoo compositions and method
AP9801369A0 (en) Dispersible macromole-cule compositions and methods for their preparation and use
EP0939640A4 (de) Verbesserungen bei polymerzusammensetzungen zur chemotherapie sowie behandlungsverfahren unter deren verwendung
EP0943327A4 (de) Arzneimittel
ZA968322B (en) Solid sillicone compositions and methods for their preparation and use
GB9619761D0 (en) Shampoo composition
GB9616351D0 (en) Vaccine composition
GB9623233D0 (en) Vaccine composition
IL111554A (en) Methods and compositions for hair treatment
EP0890599A4 (de) Polyorganosiloxane und verfahren zu deren herstellung
IL130291A0 (en) Compositions and methods for administering pneumococcal DNA
HUP0000460A3 (en) Imidazopyridazines and pharmaceutical compositions thereof
AU1829097A (en) Methods for regenerating scarless skin and compositions used therein
EP0987942A4 (de) Pharmazeutische zusammensetzung und verfahren zu ihrer verwendung
GB9606579D0 (en) Pharmaceutical composition and methods for the manufacture thereof
GB9617346D0 (en) Therapeutic methods and compositions for use therein
GB9603471D0 (en) Therapeutic methods and compositions for use therein
ZA955409B (en) Keratolytic-wound healing compositions and methods for preparing and using same
GB9604426D0 (en) Pharmaceutical composition and use thereof
GB9620592D0 (en) Pharmaceutical compositions and their use
GB9622437D0 (en) Vaccine composition
GB9622438D0 (en) Vaccine composition